Global burden of ovarian and uterine cancers attributable to high body-mass index in 204 countries and territories, 1990–2021

The global burden of ovarian and uterine cancer attributable to high BMI has increased significantly over the past three decades. Targeted interventions, including obesity prevention and cancer screening, are crucial for mitigating this burden, particularly in emerging high-risk regions. These findings underscore the need for urgent public health strategies to address obesity-related cancer risks worldwide.